Related Experiment Video
Updated: Jan 9, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
TAPB: an interventional debiasing framework for alleviating target prior bias in drug-target interaction prediction
Gaoming Lin1, Xin Zhang2,3, Zhonghao Ren4,5
1School of Computer Science and Technology, Zhejiang Normal University, Jinhua, Zhejiang, China.
This study identifies "target prior bias" in drug-target interaction prediction, caused by imbalanced target data. A new framework, TAPB, uses causal inference to correct this bias, improving model generalization for drug repurposing.
Area of Science:
- Computational Biology
- Pharmacology
- Machine Learning
Background:
- Drug-Target Interaction (DTI) prediction is crucial for drug repurposing.
- Existing DTI models suffer from
- target prior bias,
- stemming from imbalanced target label distributions in training data.
Purpose of the Study:
- To introduce a novel debiasing framework, TAPB, to address target prior bias in DTI prediction.
- To leverage causal inference to compute interventional probabilities P(Y∣D, do(T)) for accurate DTI modeling.
Main Methods:
- Amino acid randomization for feature representation.
- Confounder Alignment Module (CAM) for bias mitigation.
- Interventional training with backdoor adjustment for causal effect estimation.
Main Results:
- TAPB framework effectively alleviates target prior bias.
- Achieved competitive performance compared to existing DTI prediction methods.
- Demonstrated enhanced model generalization and provided interpretable DTI insights.
Conclusions:
- Target prior bias is a significant confounder in DTI prediction.
- TAPB offers a robust solution for accurate and generalizable DTI prediction.
- The framework enhances understanding of drug-target interaction mechanisms.
Related Concept Videos
Protein-protein Interfaces
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Quantitative Aspects of Drug-Receptor Interaction
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...

